1. Insomnia in patients with coronary heart disease: prevalence and correlates. Frøjd L. et al., Journal of Clinical Sleep Medicine, Jan 2021
2. Lavere behandlingsmål for LDL-kolesterol bør innføres. Retterstøl K., Munkhaugen J. et al., Tidsskriftet Den Norske Legeforening, Jan 2021
3. Retterstøl og medarbeidere svarer Retterstøl K., Munkhaugen J. et al, Tidsskriftet Den Norske Legeforening, Mars 2021
4. Tailored clinical management after blinded statin challenge improved long-term lipid control in coronary patients with self-perceived muscle side-effects, Sverre E. et al, European Journal of Preventive Cardiology, Mai 2021
5. Shared genetic architecture between neuroticism, coronary artery disease and cardiovascular risk factors, Torgersen K.et al., Translational Psychiatry, Jun 2021
6. Prognostic impact of non-improvement of global longitudinal strain in patients with revascularized acute myocardial infarction, Otterstad JE et al., Int J Cardiovasc Imaging, Jul 2021
7. Worry and rumination predict insomnia in patients with coronary heart disease: a cross-sectional study with long-term follow-up Frøjd L. et al, Journal of Clinical Sleep Medicine, Okt 2021
8. The relationship between directly measured statin adherence, self-reported adherence measures and cholesterol levels in patients with coronary heart disease, Kristiansen O et al, Atherosclerosis, Nov 2021
9. Rehabilitering og sekundærforebygging etter hjerteinfarkt ved sykehus, Peersen K et al, Tidsskriftet Den Norske Legeforening, Okt 2021
10. Clinical and psychological factors in coronary heart disease patients with statin associated muscle side-effects. Kari Peersen et al. BMC Cardiovascular Disorders, 2021